BI

Billion To One

NASDAQ: BLLNYC S17 ↗

San Francisco, US · Founded 2016 · 300 employees · Public · 20 known investors

billiontoone.com ↗

BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.

Founders & leadership· Y Combinator alumni (S17)

OA

Oguzhan Atay, PhDCo-Founder, CEO, and Board Chair

DT

David Tsao, PhDCo-Founder, CTO, and Board Member

OA

Oguzhan AtayinFounder

DT

David TsaoinFounder/CTO

SS

Sukrit SilasCofounder30 Under 30 2019

Investors · 20

50

500 Emerging EuropeAmsterdam

AS

Asymmetry VenturesRichmond · $125K – $500Kvia Rob Ness · inferred

CI

Civilization Ventures Management, LlcTiburon · $1M – $10M

E2

e2vc

FI

Fifty YearsSan Francisco · $250K – $2M

FR

FrialeNashville · $100K – $600Kvia Bryan Frist · inferred

HE

Hemisphere Ventures LLC

HO

HOF CapitalNew York · $25K – $15M

HU

Hummingbird VenturesBelgium · $500K – $10M

ME

MetaplanetTallinn · $500K – $10M

NE

Neotribe VenturesMenlo Park · $250K – $2M

OB

Oberland CapitalNew York · $50M – $300M

PR

Premji InvestMenlo Park

ST

Standard CapitalSan Francisco

ST

Start Capital

TI

Time BioVenturesSouthern California

TO

Toba CapitalIrvine · $1M – $10M

UP

UpHonest CapitalSilicon Valley · $50K – $1M

Y

Y CombinatorSan Francisco · $500K

LO

Lombardstreet VenturesreportedWoodside · $500K